DIMENSIONAL FUND ADVISORS LP

Position in LYEL — Lyell Immunopharma, Inc.

CIK 354204 AUSTIN, TX

Position in LYEL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$959,824

-$807 QoQ

Shares Held

68,315

+42.7% QoQ

Ownership

0.279%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#26

of 87 holders

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 79% Shared 19% None 2%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. LYEL ranks #160 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$959,824	68,315	+42.7%	Shares	Sole	2026-08-11
2026-03-31	$960,631	47,888	+255.7%	Shares	Sole	2026-05-07
2025-03-31	$7,243	13,463	0.0%	Shares	Sole	2025-05-13
2024-12-31	$8,616	13,463	-18.9%	Shares	Sole	2025-02-13
2024-09-30	$22,909	16,601	-58.6%	Shares	Sole	2024-11-07
2024-06-30	$58,142	40,098	+197.8%	Shares	Sole	2024-08-09
2024-03-31	$30,022	13,463	0.0%	Shares	Sole	2024-05-10
2023-12-31	$26,118	13,463	0.0%	Shares	Sole	2024-02-07
2023-09-30	$19,790	13,463	0.0%	Shares	Sole	2023-11-09
2023-06-30	$42,812	13,463	-68.5%	Shares	Sole	2023-08-09
2023-03-31	$100,878	42,745	-68.2%	Shares	Sole	2023-05-12
2022-12-31	$467,041	134,594	+12.8%	Shares	Sole	2023-02-09
2022-09-30	$874,271	119,273	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.